Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 948 of 6351
-
New drug duo offers hope for Hard-to-Treat lymphoma
Disease control OngoingThis research study is evaluating the combination of two drugs, copanlisib and venetoclax, as a possible treatment for trelapsed/refractory diffuse large B-cell lymphoma (DLBCL) The names of the study drugs involved in this study are: * Copanlisib * Venetoclax
Phase 1/2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New transplant approach aims to tame Graft-Versus-Host disease
Disease control OngoingReduced intensity conditioning (RIC) has emerged and been increasingly adopted as a modality to allow preparative conditioning pre transplant to be tolerated by older adults or those patients that are otherwise unfit for myeloablative conditioning. In this study, we aim to use RI…
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Timing of chemo may boost survival in pancreatic cancer
Disease control OngoingThe PREOPANC-3 study is a randomized, multicenter, phase 3 trial. Patients with resectable pancreatic cancer will be randomly assigned (1:1) to 8 cycles of neoadjuvant mFOLFIRINOX followed by surgery and 4 cycles of adjuvant mFOLFIRINOX (arm 1) or to upfront surgery followed by 1…
Phase 3 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could yearly Low-Energy laser replace daily eye drops for glaucoma?
Disease control Recruiting nowThe goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a year will prevent or delay the need for daily eye drop medications better than waiting for SLT to wear…
Phase 3 • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Weekly shot helps people with obesity and prediabetes shed pounds and fix blood sugar
Disease control CompletedThis study looks at how well a new medicine, called semaglutide, works at helping people with obesity and prediabetes. This study will look at how much weight participants lose, and if participants can go from having blood sugar that is higher than normal (prediabetes) to having…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Electric pulses may bring back lost foot sensation in diabetes
Symptom relief CompletedDiabetic polyneuropathy is a common complication of diabetes that damages the nerves of the feet and legs. Besides causing pain, it gradually reduces the ability to feel light touch on the sole of the foot. This loss of protective sensation is important because it removes the war…
Sponsor: Burdur Mehmet Akif Ersoy University • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New drug combo aims to control lymphoma without chemo
Disease control Recruiting nowThis phase II trial studies the effect of acalabrutinib and obinutuzumab in treating patients with follicular lymphoma or other indolent non-Hodgkin lymphoma for which the patient has not received treatment in the past (previously untreated). Acalabrutinib may stop the growth of …
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
One-Time gene shot aims to tame rare copper disorder
Disease control OngoingThe objectives of this clinical trial are to assess, for up to 5 years, the safety, tolerability and pharmacological activity of a single ascending doses of VTX-801, a gene therapy, administered intravenously (IV) to adult patients with Wilson's Disease prior to and following bac…
Phase 1/2 • Sponsor: Vivet Therapeutics SAS • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Teen therapy aims to stop bipolar before it starts
Prevention OngoingInvestigators will conduct a confirmatory efficacy trial of Interpersonal and Social Rhythm Therapy (IPSRT) delivered via telehealth for offspring of bipolar parents (OBP; age 12-18, n=120) at elevated risk for BP onset via risk calculator score. All participants receive a baseli…
Sponsor: University of Pittsburgh • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
500 families join quest to unlock genetic secrets of miscarriage
Knowledge-focused Recruiting nowThe overall goals of this proposal are to determine the genetic architecture of recurrent pregnancy loss (RPL) and to discover genomic predictors of RPL.
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New eczema cream shows promise in major trial
Symptom relief CompletedThis is a double-blind, randomized, vehicle controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% compared to vehicle control cream in pediatric and adult subjects with atopic dermatitis.
Phase 3 • Sponsor: Organon and Co • Aim: Symptom relief
Last updated Jun 26, 2026 13:45 UTC
-
Tight glucose control may preserve insulin-making cells in type 2 diabetes
Disease control OngoingDiabetes is a disorder of high blood glucose, that tends to get worse; over time, patients need more and more drugs. This pattern is caused by overwork of the body's insulin-producing β-cells, because patients' glucose levels are typically above normal; if the investigators kept …
Sponsor: Foundation for Atlanta Veterans Education and Research, Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Magnetic pulses to the brain may unstick Parkinson's patients who freeze when walking
Symptom relief CompletedThis study evaluated transcranial magnetic stimulation (TMS) for freezing of gait in patients with Parkinson's disease. Participants with Parkinson's disease and freezing of gait received conventional TMS protocols, and their clinical, gait, and neurophysiological outcomes were a…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Can a gentler iron pill break the anemia cycle in IBD?
Disease control CompletedThe purpose of this study is to determine whether Ferric Maltol, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with inflammatory bowel disease (IBD).
Phase 3 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Genetic test may spare patients from unnecessary thyroid surgery
Diagnosis CompletedThe purpose of this study is to evaluate the accuracy of Thyroscan in the differential diagnosis of benign and malignant thyroid nodules with suspecious ultrasound features
Sponsor: Rigen Biotech • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
Can sensory therapy calm Dementia-Related agitation in hospitals?
Symptom relief OngoingBehavioral and psychological symptoms are common among older adults hospitalized with dementia or delirium and may include agitation, wandering, delusions, hallucinations, aggression, oppositional behavior, and sleep disturbances. These symptoms can increase the risk of falls, pr…
Sponsor: Azienda Ospedaliero-Universitaria di Modena • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Can workouts and brain games shield aging brains?
Prevention CompletedThe ACTIONcardioRisk trial is designed to investigate the effect of aerobic and progressive resistance training exercises combined with cognitive training, on neurocognitive functioning of sedentary older adults with and without cardiovascular risk factors.
Sponsor: Louis Bherer • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
New Triple-Drug cocktail shows promise for Tough-to-Treat recurrent cancers
Disease control OngoingThis phase II clinical trial studies the effect of lenvatinib, pembrolizumab, and paclitaxel in treating patients with endometrial, epithelial ovarian, fallopian tube, or primary peritoneal cancer that has come back (recurrent). While all 3 study drugs are FDA approved, and 2-dru…
Phase 2 • Sponsor: Floor Backes, MD • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could this treatment stop allergies before they start? new study in infants shows promise
Prevention CompletedThis is a Phase 1b/2, randomized, double-blind, multi-center study to evaluate the safety, tolerability, and preliminary clinical efficacy of STMC-103H in neonates and infants at risk for developing allergic disease (Type 1 hypersensitivity). Subjects will be enrolled in a three-…
Phase 1/2 • Sponsor: Siolta Therapeutics, Inc. • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Breakthrough trial aims to free kidney recipients from daily pills
Disease control OngoingThe goal is to investigate the safety of the conditioning regimen, and its ability to induce donor/recipient lymphohematopoietic chimerism without Chimerism Transition Syndrome (CTS), which may result in donor-specific unresponsiveness (tolerance) to the renal allograft in the ab…
Phase 1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC